复发痣的研究进展

doi:10.35541/cjd.20220431

中华皮肤科杂志 ›› 2023, e20220431.doi: 10.35541/cjd.20220431

复发痣的研究进展

李芳王晓晴刘梦茜蒋佳怡黄淑黛王大光

南京医科大学第一附属医院皮肤科，南京 210029

收稿日期:2022-06-15 修回日期:2022-10-15 发布日期:2023-07-12
通讯作者: 王大光 E-mail:wangirwin@163.com
基金资助:
国家自然科学基金（81000703、81472896）；江苏省自然科学基金（BK2009437）；江苏省六大人才高峰C类资助项目（2015-WSW-026）

Research advances in recurrent melanocytic nevus

Li Fang, Wang Xiaoqing, Liu Mengxi, Jiang Jiayi, Huang Shudai, Wang Daguang

Department of Dermatology and Venereology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China

Received:2022-06-15 Revised:2022-10-15 Published:2023-07-12
Contact: Wang Daguang E-mail:wangirwin@163.com
Supported by:
National Natural Science Foundation of China （81000703, 81472896）; Natural Science Foundation of Jiangsu Province（BK2009437）; Six Talent Peaks of Jiangsu Province （2015-WSW-026）

摘要/Abstract

摘要： 【摘要】复发痣又称假性黑素瘤，实际是黑素细胞痣不完全去除后复发，常表现为不对称、边界不规则的色素沉着，需和黑素瘤鉴别。目前国内外对复发痣研究较少，本文综述复发痣的研究进展，主要描述其临床特征、组织病理学和免疫组化特征、鉴别诊断以及可能的病因，以期为复发痣的临床诊疗提供参考。

关键词: 色素痣, 复发痣, 痣和黑素瘤, 病理过程

Abstract: 【Abstract】 Recurrent melanocytic nevus, also known as pseudomelanoma, is recurrence of melanocytic nevus after incomplete removal. Recurrent melanocytic nevus is often characterized by asymmetric and irregularly circumscribed pigmentation, and it needs to be differentiated from melanoma. Currently, there are few studies on recurrent melanocytic nevus in China and other countries. This review summarizes research advances in recurrent melanocytic nevus, and mainly describes its clinical features, histopathological and immunohistochemical characteristics, differential diagnosis, and possible etiology, in order to provide a reference for clinical diagnosis and treatment of recurrent melanocytic nevus.

Key words: Melanocytic nevi, Recurrent melanocytic nevi, Nevi and melanomas, Pathologic processes

李芳王晓晴刘梦茜蒋佳怡黄淑黛王大光. 复发痣的研究进展[J]. 中华皮肤科杂志, 2023,e20220431. doi:10.35541/cjd.20220431

Li Fang, Wang Xiaoqing, Liu Mengxi, Jiang Jiayi, Huang Shudai, Wang Daguang. Research advances in recurrent melanocytic nevus[J]. Chinese Journal of Dermatology,2023,e20220431. doi:10.35541/cjd.20220431

参考文献 37

［1］	Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal［J］. Arch Dermatol, 1975,111（12）:1588⁃1590. doi: 10.1001/archderm.111. 12.1588.
［2］	Vilain RE, McCarthy SW, Scolyer RA. The regenerating naevus［J］. Pathology, 2016,48（2）:108⁃112. doi: 10.1016/j.pathol.2015. 12.009.
［3］	Castagna RD, Stramari JM, Chemello R. The recurrent nevus phenomenon［J］. An Bras Dermatol, 2017,92（4）:531⁃533. doi: 10.1590/abd1806⁃4841.20176190.
［4］	Oh Y, Lee SH, Lim JM, et al. Long⁃term outcomes of laser treatment for congenital melanocytic nevi［J］. J Am Acad Dermatol, 2019,80（2）:523⁃531.e12. doi: 10.1016/j.jaad.2018.08. 046.
［5］	Köse O. Efficacy of the carbon dioxide fractional laser in the treatment of compound and dermal facial nevi using with dermatoscopic follow⁃up［J］. J Dermatolog Treat, 2019,30（5）:498⁃502. doi: 10.1080/09546634.2018.1529384.
［6］	King R, Hayzen BA, Page RN, et al. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression［J］. Mod Pathol, 2009,22（5）:611⁃617. doi: 10.1038/modpathol.2009.22.
［7］	Fox JC, Reed JA, Shea CR. The recurrent nevus phenomenon: a history of challenge, controversy, and discovery［J］. Arch Pathol Lab Med, 2011,135（7）:842⁃846. doi: 10.5858/2010⁃0429⁃RAR.1.
［8］	Heck R, Ferrari T, Cartell A, et al. Clinical and dermoscopic （in vivo and ex vivo） predictors of recurrent nevi［J］. Eur J Dermatol, 2019,29（2）:179⁃184. doi: 10.1684/ejd.2019.3530.
［9］	Blum A, Hofmann⁃Wellenhof R, Marghoob AA, et al. Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society［J］. JAMA Dermatol, 2014,150（2）:138⁃145. doi: 10.1001/jamadermatol.2013.6908.
［10］	Sommer LL, Barcia SM, Clarke LE, et al. Persistent melanocytic nevi: a review and analysis of 205 cases［J］. J Cutan Pathol, 2011,38（6）:503⁃507. doi: 10.1111/j.1600⁃0560.2011.01692.x.
［11］	Hoang MP, Prieto VG, Burchette JL, et al. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation［J］. J Cutan Pathol, 2001,28（8）:400⁃406. doi: 10.1034/j.1600⁃0560. 2001.028008400.x.
［12］	Tschandl P. Recurrent nevi: report of three cases with dermatoscopic⁃dermatopathologic correlation［J］. Dermatol Pract Concept, 2013,3（1）:29⁃32. doi: 10.5826/dpc.0301a08.
［13］	Helm TN, Helm MF, Helm KF. Melanoma arising in a persistent nevus: melanoma where‘seudomelanoma′is expected［J］. JAAD Case Rep, 2021,12:5⁃7. doi: 10.1016/j.jdcr.2021.03.045.
［14］	Pogorzelska⁃Dyrbuś J, Bergler⁃Czop B, Kajor M. Recurrence of melanoma in the scar after excised Spitz nevus in a 17⁃year⁃old child［J］. An Bras Dermatol, 2021,96（4）:451⁃453. doi: 10.1016/j.abd.2020.07.014.
［15］	Jeong DK, Bae YC, Lee SJ, et al. A case of malignant melanoma after repeated recurrent dysplastic nevi［J］. Arch Craniofac Surg, 2019,20（4）:260⁃264. doi: 10.7181/acfs.2019.00283.
［16］	Walton KE, Garfield EM, Zhang B, et al. The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: a retrospective, case⁃control study［J］. J Am Acad Dermatol, 2019,80（3）:685⁃693. doi: 10.1016/j.jaad. 2018.09.030.
［17］	LeBoit PE. The morphology of tumor progression in melanoma in situ［J］. JAMA Dermatol, 2019,155（7）:775⁃776. doi: 10.1001/jamadermatol.2019.0457.
［18］	Fleming NH, Shaub AR, Bailey E, et al. Outcomes of surgical re⁃excision versus observation of severely dysplastic nevi: a single⁃institution, retrospective cohort study［J］. J Am Acad Dermatol, 2020,82（1）:238⁃240. doi: 10.1016/j.jaad.2019.07.033.
［19］	Moreno A, Manrique⁃Silva E, Virós A, et al. Histologic features associated with an invasive component in lentigo maligna lesions［J］. JAMA Dermatol, 2019,155（7）:782⁃788. doi: 10.1001/jamadermatol.2019.0467.
［20］	Bsirini C, Smoller BR. Histologic mimics of malignant melanoma［J］. Singapore Med J, 2018,59（11）:602⁃607. doi: 10.11622/smedj.2018041.
［21］	Dass SE, Huizenga T, Farshchian M, et al. Comparison of SOX⁃10, HMB⁃45, and melan⁃A in benign melanocytic lesions［J］. Clin Cosmet Investig Dermatol, 2021,14:1419⁃1425. doi: 10. 2147/CCID.S333376.
［22］	Santandrea G, Valli R, Zanetti E, et al. Comparative analysis of PRAME expression in 127 acral and nail melanocytic lesions［J］. Am J Surg Pathol, 2022,46（5）:579⁃590. doi: 10.1097/PAS. 0000000000001878.
［23］	Krajisnik A, Gharavi NM, Faries MB, et al. Immunohisto⁃chemistry for preferentially expressed antigen in melanoma in the differential diagnosis of melanocytic lesions of the nail apparatus［J］. Am J Dermatopathol, 2022,44（7）:488⁃492. doi: 10.1097/DAD.0000000000002143.
［24］	Lezcano C, Jungbluth AA, Nehal KS, et al. PRAME expression in melanocytic tumors［J］. Am J Surg Pathol, 2018,42（11）:1456⁃1465. doi: 10.1097/PAS.0000000000001134.
［25］	Googe PB, Flanigan KL, Miedema JR. Preferentially expressed antigen in melanoma immunostaining in a series of melanocytic neoplasms［J］. Am J Dermatopathol, 2021,43（11）:794⁃800. doi: 10.1097/DAD.0000000000001885.
［26］	Raghavan SS, Wang JY, Kwok S, et al. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features［J］. J Cutan Pathol, 2020,47（12）:1123⁃1131. doi: 10.1111/cup.13818.
［27］	Ko JS, Matharoo⁃Ball B, Billings SD, et al. Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes［J］. Cancer Epidemiol Biomarkers Prev, 2017,26（7）:1107⁃1113. doi: 10. 1158/1055⁃9965.EPI⁃16⁃0958.
［28］	Nishimura EK, Jordan SA, Oshima H, et al. Dominant role of the niche in melanocyte stem⁃cell fate determination［J］. Nature, 2002,416（6883）:854⁃860. doi: 10.1038/416854a.
［29］	Sun Q, Rabbani P, Takeo M, et al. Dissecting Wnt signaling for melanocyte regulation during wound healing［J］. J Invest Dermatol, 2018,138（7）:1591⁃1600. doi: 10.1016/j.jid.2018.01. 030.
［30］	Yardman⁃Frank JM, Fisher DE. Skin pigmentation and its control: from ultraviolet radiation to stem cells［J］. Exp Dermatol, 2021,30（4）:560⁃571. doi: 10.1111/exd.14260.
［31］	Hu S, Chen Y, Zhao B, et al. KIT is involved in melanocyte proliferation, apoptosis and melanogenesis in the Rex Rabbit［J］. PeerJ, 2020,8:e9402. doi: 10.7717/peerj.9402.
［32］	Sohn S, Kim S, Kang WH. Recurrent pigmented macules after q⁃switched alexandrite laser treatment of congenital melanocytic nevus［J］. Dermatol Surg, 2004,30（6）:898⁃907; discussion 907. doi: 10.1111/j.1524⁃4725.2004.30258.x.
［33］	D′Arcy C, Kiel C. Cell adhesion molecules in normal skin and melanoma［J］. Biomolecules, 2021,11（8）:1213. doi: 10.3390/biom11081213.
［34］	Li L, Fukunaga⁃Kalabis M, Yu H, et al. Human dermal stem cells differentiate into functional epidermal melanocytes［J］. J Cell Sci, 2010,123（Pt 6）:853⁃860. doi: 10.1242/jcs.061598.
［35］	Wang DG, Huang FR, Chen W, et al. Clinicopathological analysis of acquired melanocytic nevi and a preliminary study on the possible origin of nevus cells［J］. Am J Dermatopathol, 2020,42（6）:414⁃422. doi: 10.1097/DAD.0000000000001599.
［36］	Kunisada T, Yamazaki H, Hirobe T, et al. Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis［J］. Mech Dev, 2000,94（1⁃2）:67⁃78. doi: 10.1016/s0925⁃4773（00）00308⁃7.
［37］	Aoki H, Yamada Y, Hara A, et al. Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non⁃cutaneous and dermal versus epidermal melanocytes［J］. Development, 2009,136（15）:2511⁃2521. doi: 10.1242/dev.037168.

[1]	宋雨晴杨楠刘琳琳冯子仪韩世新周梅娟. [开放获取] 皮肤磨削术治疗家族性良性慢性天疱疮6例临床观察[J]. 中华皮肤科杂志, 2024, 0(4): 20220278-e20220278.
[2]	陈立新王莹高西波秦蓓李钦峰. 儿童经典型和色素减退型扁平疣反射式共聚焦显微镜特征及与组织病理的对应关系初探[J]. 中华皮肤科杂志, 2024, 57(3): 249-253.
[3]	董栋刘天一. 细胞代谢与皮肤恶性黑素瘤转移的研究进展[J]. 中华皮肤科杂志, 2023, 56(9): 878-881.
[4]	邵依王雷刘芳. 蕈样肉芽肿伴大细胞转化和原发性皮肤间变性大细胞淋巴瘤临床病理比较分析[J]. 中华皮肤科杂志, 2023, 56(9): 853-857.
[5]	李嘉祺叶枫鞠强. 表皮葡萄球菌共生性稳态与皮肤疾病[J]. 中华皮肤科杂志, 2023, 56(5): 459-462.
[6]	任发亮王华肖异珠. 透明细胞丘疹病57例临床特征分析[J]. 中华皮肤科杂志, 2023, 56(4): 309-312.
[7]	杨永婷李婷婷康晓静. 黑素瘤免疫检查点抑制剂治疗相关的生物标志物研究进展[J]. 中华皮肤科杂志, 2023, 56(3): 278-283.
[8]	王媛丽刘玲孙中斌李凯. 临床误诊为黑素瘤的其他疾病141例分析[J]. 中华皮肤科杂志, 2023, 56(3): 244-246.
[9]	陈启韬李煜乾邵光辉朱晶朱麒麟李中明杜旭峰范卫新. 头皮糜烂性脓疱性皮病研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210803-e20210803.
[10]	郑娜娜曾荣, 陶盈凯李岷, . 环状RNA与皮肤肿瘤相关性研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210893-e20210893.
[11]	李婷婷康晓静. 肠道菌群与黑素瘤免疫检查点抑制剂治疗的研究进展[J]. 中华皮肤科杂志, 2023, 56(2): 177-180.
[12]	陈凤鸣王雷高天文刘宇. 先天性色素痣恶变98例临床及病理分析[J]. 中华皮肤科杂志, 2023, 56(11): 1028-1034.
[13]	曹蒙洪安澜王焱方方. 儿童黑素瘤临床研究进展[J]. 中华皮肤科杂志, 2023, 56(11): 1074-1078.
[14]	邓磷君涂平. 玫瑰糠疹110例组织病理分析[J]. 中华皮肤科杂志, 2023, 56(10): 943-945.
[15]	王逸飞宋昊缪秋菊徐秀莲孙建方. 结缔组织痣的临床分型及组织病理研究进展[J]. 中华皮肤科杂志, 2023, 56(1): 82-85.

复发痣的研究进展

Research advances in recurrent melanocytic nevus

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 37

相关文章 15

Metrics

本文评价

推荐阅读 10